Search Within

Jedd D Wolchok

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (108)
  2. Journal Article (84)
  3. Editorial (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (195)
  2. GSK Faculty (195)
  3. Melanoma and Immunotherapeutics Service (195)
  4. Sloan Kettering Institute Postdocs (195)
  5. Solid Tumor Oncology Division (195)
  6. Sloan Kettering Institute Faculty (62)

More Groups

People
  1. Taha Merghoub (160)
  2. Sadna Budhu (69)
  3. Roberta Zappasodi (49)
  4. Cailian Liu (43)
  5. Daniel Hirschhorn Cymerman (41)
  6. Hong Zhong (28)

More People

Years
  1. 2023 (5)
  2. 2022 (29)
  3. 2021 (19)
  4. 2020 (20)
  5. 2019 (17)
  6. 2018 (29)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (42)
  2. Cancer Research (27)
  3. Journal of Immunology (12)
  4. Journal of Clinical Oncology (8)
  5. Journal of Investigative Dermatology (8)
  6. Nature (8)

More Publications

Publishers
  1. Biomed Central Ltd (43)
  2. American Association for Cancer Research (42)
  3. Nature Publishing Group (17)
  4. Cell Press (14)
  5. The American Association of Immunologists, Inc (12)
  6. American Society of Clinical Oncology (8)

More Publishers

Results (195)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development of optimized car T cells for therapy of glioblastoma
    Meeting Abstract

    Khan, J.; Cai, W.; Yang, Y.; Dong, L.; Hopland, K.; Yu, K. K. H.; Freeman, R.; Purdon, T.; Tabar, V.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immunogenic landscape and therapeutic targeting of mutant NRAS "public" neoantigens
    Meeting Abstract

    Etxeberria, I.; Banks, L.; Chandran, S.; Correa, A.; Novak, B.; Fleischman, J.; Drilon, A.; Wolchok, J.; Merghoub, T.; Klebanoff, C.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Potential role of CD47 in T cell exhaustion program
    Meeting Abstract

    Weng, C. H.; Samaan, F.; Budhu, S.; Mangarin, L.; Monette, S.; Liu, C.; Pourpe, S.; Hamadene, L.; Zhong, H.; Yang, X.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Defining the balance of anti-viral and anti-tumor T cell responses to oncolytic virus therapy using single cell approaches
    Meeting Abstract

    Burman, B.; Ceglia, N.; Hirschhorn, D.; Budhu, S.; Mangarin, L.; Oseledchyk, A.; Bykov, Y.; McPherson, A.; Shah, S.; Wolchok, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologic inhibition of the glycolytic pathway improves response to immune checkpoint blockade
    Meeting Abstract

    Verma, S.; Serganova, I.; Budhu, S.; Dong, L.; Ko, M.; Mangarin, L.; Merghoub, T.; Wolchok, J.; Zappasodi, R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • APR-246 enhances tumor immunogenicity even in the absence of p53
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Liu, C.; Budhu, S.; George, M. M.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model
    Meeting Abstract

    George, M. M.; Warner, A. B.; Hamadene, L.; Hirschhorn, D.; Houghton, A. N.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma
    Meeting Abstract

    Balachandran, V. P.; Rojas, L. A.; Sethna, Z.; Soares, K.; Derhovanessian, E.; Mueller, F.; Yadav, M.; Basturk, O.; Gonen, M.; Wei, A. C. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save